Clinical trial
A Phase II Study of Bevacizumab in Patients With Nonresectable Cancer of the Adrenal Cortex.
NCT00469469 is registered in ClinicalTrials.gov with Dartmouth-Hitchcock Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Bevacizumab in Patients With Nonresectable Cancer of the Adrenal Cortex.
- Lead sponsor
- Dartmouth-Hitchcock Medical Center
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- May 31, 2007
- Completion date
- September 30, 2009
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.